Courses

← vista completa

Published on June 1, 2001 | http://doi.org/10.5867/medwave.2002.05.3187

Polycystic ovarian syndrome, obesity and hyperinsulinemia: a path to diabetes

Síndrome de ovario poliquístico, obesidad e hiperinsulinismo: un camino a la diabetes

Teresa Sir Peterman

This work is licensed under a Creative Commons Attribution 4.0 International License. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Authors

Teresa Sir Peterman

Facultad de Medicina, Universidad de Chile, Santiago, Chile

Figures

Article has no figures.

Forum

No messages

History

Citation Sir Peterman T. Polycystic ovarian syndrome, obesity and hyperinsulinemia: a path to diabetes. Medwave 2002;2(05):e3187 doi: 10.5867/medwave.2002.05.3187

Submission date 01/01/1970

Acceptance date 01/01/1970

Publication date 01/06/2001

Index

Metrics

Not available at the moment.

Notes

References

  1. Ibáñez L, Potau N, Chacon P, Pascual C, Carrascosa A. Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 1998 Sep;41(9):1057-63. | PubMed
  2. Sir T, Castillo T, Muñoz S, López G, Calvillán m. Effects of metformin on insulin resistance in obese and hyperandrogenic women. Rev Med Chil. 1997 Dec;125(12):1457-63. | PubMed
  3. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, et al. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 2001 Jan;107(2):181-9. | CrossRef | PubMed
  4. Benítez R, Sir-Petermann T, Palomino A, Angel B, Maliqueo M, Pérez F,et al. Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome. Rev Med Chil. 2001 Jul;129(7):707-12. | PubMed
  5. Larsson B, Bengtsson C, Björntorp P, Lapidus L, Sjöström L, Svärdsudd K, et al. Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, Sweden. Am J Epidemiol. 1992 Feb 1;135(3):266-73. | PubMed
  6. Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol. 1995 Jul;15(7):821-6. | CrossRef | PubMed
  7. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999 Jan;84(1):165-9
  8. Conn JJ, Jacobs HS, Conway GS. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrino. 2000 Jan; 52(1):81-6. | CrossRef | PubMed